Atezolizumab in combination with obinutuzumab and lenalidomide demonstrates favorable activity and manageable toxicity in patients with relapsed/refractory follicular lymphoma (FL): An interim analysis of a phase Ib/II trial Meeting Abstract
| Authors: | Salles, G.; Ghosh, N.; Lossos, I. S.; Palomba, M. L.; Mehta, A.; Casasnovas, O.; Stevens, D.; Abajo, A.; Nielsen, T.; Chitra, S.; Wenger, M.; Morschhauser, F. |
| Abstract Title: | Atezolizumab in combination with obinutuzumab and lenalidomide demonstrates favorable activity and manageable toxicity in patients with relapsed/refractory follicular lymphoma (FL): An interim analysis of a phase Ib/II trial |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837604271 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-114992 |
| Notes: | Meeting Abstract: 1603 -- Source: Wos |
